MGNX compared with IRWD: revenue, margins and what each company keeps, and the suppliers and customers both name

MGNXMacrogenics Inc

Mkt capRevenueRevenue

IRWDIronwood Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

MGNXMacrogenics Inc

IRWDIronwood Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MGNX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.1%▲+3.43%×0.24

IRWD

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.6%▲+2.65%×0.17

May 7 '26±11.8%▼−13.66%×1.16

= impliedMGNX realized, solidIRWD realized, hatchedOne scale, both sides: full bar = 29%× = |realized| ÷ impliedSource: market data

Q1 FY26

±22.4%

▼−11.35%

×0.50

Jan 2 '26±28.3%▲+26.71%×0.94

MGNXMacrogenics Inc

2.34▲+0.43%· post 2.34· delayed

Mkt cap$148.4MRevenue$33MQ2 FY26Revenue$134MFY25

IRWDIronwood Pharmaceuticals Inc

3.51▲+1.45%· post 3.51· delayed

After hoursNov 3 '26delayed

Mkt cap$571.7MRevenue$113MQ2 FY26Revenue$296MFY25

Compare

After hoursNov 3 '26delayed

MGNXMacrogenics Inc

IRWDIronwood Pharmaceuticals Inc

2.34▲+0.43%post 2.34delayed

Price

3.51▲+1.45%post 3.51delayed

$148.4M

Mkt cap

$571.7M

Q2 FY26$33M

Revenue

$113MQ2 FY26

FY25$134M

Revenue

$296MFY25

MGNX2.34▲+0.43%vsIRWD3.51▲+1.45%After hoursNov 3 '26delayed